DANIEL DAWSON: Open Payments
NPI 1760757413 · YOUNGSTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 26 payments from 7 companies in 2025. Trend: 2023 $1,307 · 2024 $1,607 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 17 | $160 |
| Alkermes, Inc. | 2 | $59 |
| Lundbeck LLC | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: COBENFY, CAPLYTA, LYBALVI, ARISTADA, INGREZZA, REXULTI, Auvelity, ABILIFY MAINTENA.
Industry payments across OH — which companies pay providers there.
